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Abstract
Introduction: Good’s Syndrome is a rare cause of immunodeﬁciency associated with thymoma.
Patients with this syndrome are prone to infections with encapsulated microorganisms. The
diagnosis may be delayed for a considerable time period even after the thymectomy.
Case presentation: We describe the case of a 70-year-old woman with a background of thymec-
tomy who presented with pneumonia and gram negative sepsis. Haemophilus inﬂuenzae was
found in blood cultures. Moreover, there was evidence of impaired B and T cell immunity con-
sistent with Good’s Syndrome. She was commenced on immunoglobulin replacement following
treatment of sepsis and remains well 18 months after the initial presentation.
Conclusion: This case illustrates the importance of considering Good’s Syndrome in the con-
text of pneumonia and immunodeﬁciency associated with encapsulated organisms such as
Haemophilus inﬂuenzae. This clinical entity is associated with a signiﬁcant mortality and should
be considered as a cause of immunodeﬁciency even years after thymectomy.
© 2010 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L. All rights
reserved.
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Pneumonia por Haemophilus Inﬂuenzae e imunodeﬁciência associadas a timoma --
uma apresentac¸ão da Síndrome de Good
Resumo
Introduc¸ão: A Síndrome de Good é uma causa rara da imunodeﬁciência associada ao timoma.
Os pacientes com esta síndrome são propensos a infecc¸ões por microrganismos encapsulados.
O diagnóstico pode ser atrasado por bastante tempo, mesmo após a timectomia.
Apresentac¸ão do Caso: Descrevemos o caso de uma mulher de 70 anos com antecedentes de
timectomia, que apresentava pneumonia e sepsis por agente gram negativo. O Haemophilus
inﬂuenzae foi isolado em hemoculturas. Além disso, evidência de alterac¸ões da imunidade
celular B e T, consistente com a Síndrome de Good. A doente iniciou terapêutica de substituic¸
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ão com imunoglobulina seguida de tratamento da sepsis e continua bem 18 meses após a
apresentac¸ão inicial.
Conclusão: Este caso ilustra a importância de considerar a Síndrome de Good no contexto
da pneumonia e imunodeﬁciência associadas a organismos encapsulados, como Haemophilus
inﬂuenzae. Esta entidade clínica está associada a uma mortalidade signiﬁcativa e deve ser
considerada como uma causa de imunodeﬁciência mesmo anos depois da timectomia.
© 2010 Sociedade Portuguesa de Pneumologia. Publicado por Elsevier España, S.L. Todos os
direitos reservados.
Figure 1 Chest radiograph at presentation suggestive of
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0.610mg/L (protective level >1mg/L)]. She was commenced
on immunoglobulin replacement therapy to prevent further
severe infective episodes in future. At 18-month follow up
she is currently well.
Table 1 Immunoglobulin and lymphocyte subset analysis.
Result Reference
IgA 0.31 g/L 0.8--4.0
IgG 4.7 g/L 6--16.1
IgM 0.07 g/L 0.5--2.0
IgG subclass 1 3.9 g/L 3.2--10.2
IgG subclass 2 0.92 g/L 1.2--6.6
IgG subclass 3 0.09 g/L 0.2--1.9
IgG subclass 4 0.03 g/L 0.0--1.3
Total lymphocytes 0.380× 109/L 1.5--3.5
T lymphocytes 0.379× 109/L 0.8--2.7
B lymphocytes 0.001× 109/L 0.1--0.6Case history
A 70-year-old woman presented to our medical assessment
unit with a 4-week history of breathlessness, productive
cough, weight loss and lethargy. She was a lifelong non-
smoker. There was no history of chest pain, wheeze or
hemoptysis. She had been recently treated with amoxicillin
for a lower respiratory tract infection. Her past medical
history included a minimally invasive type AB thymoma sur-
gically resected 2 years previously. She had not received any
chemo-radiotherapy. She had been thoroughly investigated
1 year previously with colonoscopy and abdominal/pelvic
CT scan for chronic diarrhea of 2 years’ duration. How-
ever, no abnormalities were found. There was no past
history of recurrent infections and there was no family his-
tory of immunodeﬁciency. However, there was evidence of
immunoglobulin reduction (IgA 0.42 g/L, IgM 0.20 g/L and
normal IgG) at the time of thymic resection.
On examination, she was apyrexial but tachycardic with
PR 117/min and BP 104/68mmHg. There was no clubbing
or lymphadenopathy. There were bilateral basal crackles
on chest examination. The remainder of the examina-
tion was unremarkable. Oxygen saturations were 88% on
air with type 1 respiratory failure while receiving 28%
oxygen [Arterial blood gas (pO2 6.5 kPa, pCO2 5 kPa, pH
7.50, HCO3 26mmol/L)]. Initial laboratory tests showed
mild anaemia with Hb 10.4 g/dl, WCC 4.5× 109/L and
platelets 187× 109/L. The differential count showed lym-
phopenia of 0.38× 109/L (normal range 1.5--3.5). She had
mild hyponatraemia with Na 131mmol/L. C-reactive pro-
tein was markedly elevated to 295mg/L. Chest radiograph
on admission revealed bilateral basal consolidation (Fig. 1).
She was commenced on treatment for community acquired
pneumonia with co-amoxiclav and clarithromycin. Blood cul-
tures showed a growth of gram negative bacilli, Haemophilus
inﬂuenzae, which was sensitive to all common antimicro-
bial agents. Subsequent sputum culture revealed growth
of Pseudomonas aeruginosa and Candida albicans. Screen-
ing for HIV and CMV IgM was negative. A thoracic CT scan
conﬁrmed radiographic ﬁndings of bilateral basal consolida-
tion with minimal pleural effusions, without any evidence of
malignant disease in lung parenchyma or pleura.
In view of the lymphopenia, lymphocyte subsets were
obtained which showed that B cells were absent and
markedly reduced T lymphocytes and natural killer (NK) cells
(Table 1). Moreover, there was panhypogammaglobulinemia
on immunoglobulin analysis. A full autoimmunity study was
done which was negative. These ﬁndings of combined B
and T cell deﬁciency in the context of previous thymomaonsolidation at the both lung bases (predominantly on the left
ide).
uggested the diagnosis of Good’s Syndrome. She responded
ell to antimicrobials and supportive care. Her functional
ntibody responses were found to be abnormal [Tetanus IgG
.230mg/L (protective level >2.5mg/L), Pneumococcal IgG
6.9mg/L (protective level >30mg/L) and Haemophilus IgGCD4 count 0.180× 109/L 0.4--1.7
CD8 count 0.187× 109/L 0.3--1.2
NK cells 0.018× 109/L 0.09--0.6
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iscussion
ood’s Syndrome is a rare cause of combined B and T
ell immunodeﬁciency which predisposes the individual to
acterial infections with encapsulated organisms as well
s opportunistic fungal and viral infections. It was origi-
ally described by Dr Robert Good1 who described a case
f hypogammaglobulinemia associated with thymoma. The
xact cause and pathogenesis of this syndrome is unknown,
owever it is suggested that it is a bone marrow defect asso-
iated with pre-B cell lymphopenia.2 Moreover, there is also
vidence of frequent co-existence of eosinopenia3 with this
yndrome.
The clinical features of this disorder are variable. It usu-
lly presents in the 4th or 5th decade of life with symptoms
ue to thymoma, including cough, dysphagia, dyspnea or
oarseness of voice or related to associated infections (as
oted in the case presented), the most common being recur-
ent sinopulmonary infection secondary to encapsulated
rganisms.4 As described in our case, about 50% of patients
ith Good’s Syndrome develop diarrhea which might be
econdary to inﬂammatory colitis seen in patients with com-
on variable immunodeﬁciency (CVID), or idiopathic as no
athogens are isolated in the majority of patients. Further-
ore, CMV colitis may be a potential cause of increased
owel frequency and an infectious cause of diarrhea includ-
ng enteric bacteria, CMV and giardia should be excluded as
art of the investigation in patients with Good’s Syndrome.
In terms of laboratory ﬁndings, anaemia is commonly
ssociated with immunodeﬁciency and is seen in up to
0% of patients. The cause of anemia may well be pure
ed cell aplasia,5 pernicious anemia6 or hemolytic anemia.7
he most common micro-organisms associated with Good’s
yndrome are encapsulated bacteria. Tarr and co workers
eported that Haemophilus inﬂuenzae was grown in 24% and
treptococcus pneumoniae was isolated in 8% of their analy-
es of 51 cases of Good’s Syndrome. The most common viral
nfection associated with this syndrome is cytomegalovirus.
oreover, herpes simplex and varicella zoster may be iso-
ated in some cases.
The predominant immunological ﬁndings in Good’s Syn-
rome are hypogammaglobulinemia, reduced/absent B cells
nd CD4+ T cell lymphopenia. The pathogenesis of the
mmunoglobulin deﬁciency is not fully understood. Oritani
nd colleagues8 have shown that limitin, an interferon like
ytokine, can inhibit B cell growth and differentiation. More-
ver, there is evidence that thymus itself can inﬂuence
recursor B cell growth and maturation.9 A unique immuno-
ogical ﬁnding in this case was a profound deﬁciency of NK
ells and it would be interesting to investigate and monitor
his aspect to gain further insight into this disorder.
The management of Good’s Syndrome includes surgical
esection of the thymoma. The most signiﬁcant indica-
or of prognosis is the completeness of surgical resection.
dvanced stage tumors may need combination radiother-
py with or without chemotherapy. The histology is usually
spindle cell variant but epithelial and mixed tumors
ave been noted as well. Medical management involves
rompt treatment of infection, identiﬁcation and manage-
ent of concomitant bronchiectasis and immunoglobulinA. Fahim et al.
eplacement. It is important to note that the surgical
emoval of thymoma does not reverse the immunoglob-
lin deﬁciency as evidenced by this case where the
atient presented 2 years after her surgery. Further-
ore, immunoglobulin replacement therapy is shown to
educe the incidence of infections including sinopul-
onary infections.4 Functional antibody responses to
etanus toxoid, Haemophilus B and Pneumococcal capsu-
ar polysaccharide antigen should be tested prior to the
ommencement of immunoglobulin replacement.
The prognosis of Good’s Syndrome is worse than X linked
gammaglobulinaemia and CVID10 and mortality of approxi-
ately 45% has been reported in a systematic review of 152
atients with this syndrome.11 The predominant cause of
eath is infection associated with immunodeﬁciency and it
s important to recognize and treat infectious complications
n this disease to improve mortality.
In conclusion, this case illustrates the importance of
onsidering the possibility of Good’s Syndrome in patients
ith gram negative bacteraemia and chronic diarrhea in
he context of immunodeﬁciency. Moreover, it highlights
he importance of evaluating immune status even years
fter the diagnosis of thymoma. In appropriate clinical con-
ext, Good’s Syndrome should be suspected despite normal
mmune status at the time of the diagnosis of thymoma.
lose collaboration between immunologists, microbiologists
nd physicians is invaluable for appropriate management of
his rare disease of combined B and T cell immunodeﬁciency.
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